Answers are grounded in this paper and cite their sources.
Cytoreductive surgery is a major procedure to treat advanced-stage epithelial ovarian cancer by removing tumors and nearby tissues to which the cancer may have spread. Current intraoperative procedures largely rely on the surgeon's discretion, such as naked-eye gross inspection and palpation, which is highly variable. To enhance the precision of fluorescence-guided surgery (FGS) in detecting small peritoneal tumors, we optimized the formulation of CypH-11, a sprayable near-infrared (NIR) tumor-responsive fluorogenic probe. Here, CypH-11 was formulated with the nonionic ethoxylated solubilizer Kolliphor HS 15 and sprayed directly on the exposed abdomen of ovarian tumor-bearing mice. During cytoreductive surgery aided by CypH-11, combined with or without neoadjuvant therapy, we successfully detected and excised submillimeter tumors (<1 mm in diameter) using an FDA-approved NIR video imaging system. Importantly, the overall specificity, which is represented by the true-positive rate for excised tumors, was over 90%, and the false-negative rate was only 2.6%. This fast-acting, easy-to-apply CypH-11 spray can be a powerful tool for real-time FGS, allowing surgeons to visualize and resect tiny tumors without systemic toxicity, thereby achieving a more complete resection of peritoneally disseminated tumors.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: